TipRanks
Go Ultimate55% OFF

Moleculin Biotech (MOL) Balance Sheet

Moleculin Biotech Balance Sheet

Moleculin Biotech's total assets for Q2 2026 were $21.09M, a decrease of 9.74% from the previous quarter. DE:MOL total liabilities were $9.50M for the fiscal quarter, a 16.14% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 22.13M$ 16.93M$ 38.22M$ 57.42M$ 84.09M
$ 7.12M$ 10.95M$ 12.14M$ 5.23M$ 5.10M
$ 15.01M$ 5.98M$ 26.07M$ 52.19M$ 78.99M

Currency in USD

Moleculin Biotech Debt to Assets

030M60M90M0 %25 %50 %75 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets